Support to the World Health Organization (WHO) for Response to the Ebola Virus Disease Outbreak in Western Africa


The objective of the project is to contribute to on-going efforts to reduce the morbidity, mortality and to break the chain of transmission of EVD by strengthening capacities at the district level of affected countries in western Africa to actively find, investigate and refer cases, register all potential contacts and monitor them for symptom development, strengthen data collection, reporting and analysis, and promote appropriate messaging for behavior change. This project also aims to address other public health issues in the affected countries that are exacerbated by the EVD outbreak.

General information about this opportunity
Last Known Status
Program Number
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Cooperative Agreements
Program Accomplishments
Not Applicable.
Public Health Service Act Sections 317A and 317B 317(k)(2) of the Public Health Service Act [42 U.S.C Sections 247b and 247b-2and 247b-3 ] as amended.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
World Health Organization (WHO). For purposes of this document, the term “WHO” includes its regional offices (e.g., PAHO, EMRO, AFRO, SEARO, etc.).
Beneficiary Eligibility
Individuals worldwide, including the U.S.
No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
Funds for this program will be provided via a supplemental award under the existing CDC-WHO cooperative agreement (FOA CK14-1402).
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 30 to 60 days. Funds will be awarded as a supplement to the existing CDC-WHO cooperative agreement. Award is expected to be made within 30 days.
Not Applicable.
Annual renewals within an awarded multi-year project period are subject to the availability of funds and are made via a non-competitive process. Additional renewal info can be found in the published FOA CK14-1402.
How are proposals selected?
Not Applicable.
How may assistance be used?
Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. Financial and technical resources are intended to be used for non-research activities necessary to complete the objectives stated above. The full list of restrictions for this program are included in the published Funding Opportunity Announcement for CK14-1402. General restrictions that apply are as follows:
-Recipients may not use funds for research or clinical care
-Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.
-Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.
-The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. Funds awarded to grantees are fully discretionary.
What are the requirements after being awarded this opportunity?
No program reports are required. No later than 10 days after the end of each calendar quarter, recipients must submit a calendar quarter cash transaction report (SF-272 or top portion of the SF-425 Financial Report Form) to the Payment Management System (PMS). Annual Progress Reports (APR) are due at 15 months and 27 months during the budget/project period period. Additional instructions regarding progress reporting requirements will be described in the official Notice of Award (NoA) from the CDC Procurement and Grant Office and can also be found in the published FOA CK14-1402. Federal Financial reports (SF-425) are due no at 15 months, and 27 months during the budget/project period. The final progress report is due 90 days after the end of the project period. No performance monitoring is required.
No audits are required for this program.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years after the end of a period of performance. If questions still remain, such as those raised as result of an audit, records must be retained until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is available for a 36-month budget period within project periods ranging from one to three years. Method of awarding/releasing assistance: lump sum.
Who do I contact about this opportunity?
Regional or Local Office
See Regional Agency Offices.
Headquarters Office
Theresa K. Turski 1600 Clifton Road, NE
Mailstop E93
, Atlanta, Georgia 30329 Email: Phone: 404-639-7411
Website Address
Financial Information
Account Identification
(Cooperative Agreements) FY 14 $0; FY 15 est $50,000,000; and FY 16 est $0 - Funds for this program are expected to be awarded in FY2015. Anticipated award amount is approximately $50M.
Range and Average of Financial Assistance
Range and Average Award for FY2015: Approx $50M.
Regulations, Guidelines and Literature
Regulations governing this program can be found in the published Funding Opportunity Announcement and official Notice of Award (NoA). Regulations are also published under 42 CFR 55b. Guidelines are available under 45 CFR 92, and also HHS Grants Policy Statement at
Examples of Funded Projects
Not Applicable.